Trial of Propranolol in Children and Youth With Autism Spectrum Disorder and Predictors of Response
Status:
Completed
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out how the brain of people with autism is affected by
Propranolol. Propranolol is not FDA approved for the treatment of autism. Propranolol is FDA
approved for the treatment of heart conditions such as blood pressure
This research is being done because there are currently no drug treatment options for
language impairments and social difficulties often experienced by people with autism.